NorthWest Biotherapeutics Inc (NWBO)

[GinGinGin]

and the subgroup analysis they are hyping is what is called exploratory

I disagree. Please read the "Treatment Arms vs. Subgroups" section at https://www.cvmresearch.com/p/cel-sci-cvm-fdas-recent-subgroup

Following section reasons about the pre-selection method. It is a bit of a gamble. What really puts multikine in a strong position is the outstanding safety profile - you can essentially administer it to everybody without a worry.